Cargando…
Systemic exposure following intravitreal administration of therapeutic agents: an integrated pharmacokinetic approach. 1. THR-149
Intravitreal (IVT) injection of pharmacological agents is an established and widely used procedure for the treatment of many posterior segment of the eye diseases. IVT injections permit drugs to reach high concentrations in the retina whilst limiting systemic exposure. Beyond the risk of secondary c...
Autores principales: | Vanhove, Marc, Noppen, Bernard, Wagner, Jean-Marc, Van Bergen, Tine, Barbeaux, Philippe, Stitt, Alan W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604835/ https://www.ncbi.nlm.nih.gov/pubmed/34302260 http://dx.doi.org/10.1007/s10928-021-09773-w |
Ejemplares similares
-
Systemic exposure following intravitreal administration of therapeutic agents: an integrated pharmacokinetic approach. 2. THR-687
por: Vanhove, Marc, et al.
Publicado: (2021) -
Targeting Plasma Kallikrein With a Novel Bicyclic Peptide Inhibitor (THR-149) Reduces Retinal Thickening in a Diabetic Rat Model
por: Van Bergen, Tine, et al.
Publicado: (2021) -
A novel assay based on pre-equilibrium titration curves for the determination of enzyme inhibitor binding kinetics
por: Noppen, Bernard, et al.
Publicado: (2021) -
Functional Analysis of the Ser149/Thr149 Variants of Human Aspartylglucosaminidase and Optimization of the Coding Sequence for Protein Production
por: Banning, Antje, et al.
Publicado: (2017) -
Phase 1 Dose-Escalation Study of Plasma Kallikrein Inhibitor THR-149 for the Treatment of Diabetic Macular Edema
por: Dugel, Pravin U., et al.
Publicado: (2021)